The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.
Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the key to stopping the condition in its tracks. It is well established that ...
Add Yahoo as a preferred source to see more of our stories on Google. A new drug could halt the progression of Alzheimer’s disease. Trials suggest the treatment, called trontinemab, could be the most ...
The experimental drug lecanemab shows "potential" as an Alzheimer's disease treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association ...
While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in the brain, they have struggled to understand how these harmful fragments are ...
Anavex Life Sciences' OLE study demonstrates that its Alzheimer's drug works for years beyond the clinical study. The OLE expands efficacy to include patients' behavioral abilities. The Anavex drug ...
With few treatments available to stop or reverse Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline. Alzheimer’s cases are rising in the ...
Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team found that removing an enzyme from neurons in the brain substantially reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results